Search research articles
Contact Us
Filters
Showing results (131-140 of 203) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas
Lauren H Boal, John Glod, Melissa Spencer, et al.
Acta Neuropathologica Communications
|
June 21, 2024
snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response
Cameron Church, Christian X Fay, Emil Kriukov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor
John Glod, Fernanda I Arnaldez, Lori Wiener, et al.
Pediatric Blood & Cancer
|
June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol
Mary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
Pediatric Blood & Cancer
|
January 6, 2015
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors
Srivandana Akshintala, Leigh Marcus, Katherine E Warren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2012
Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors
Melinda S Merchant, James I Geller, Kristin Baird, et al.
Journal of the National Cancer Institute
|
November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future
Karlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
Neuro-Oncology Advances
|
May 12, 2021
Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo
Sara H Osum, Alexander W Coutts, Dylan J Duerre, et al.
Sarcoma
|
February 25, 2020
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
AeRang Kim, Yao Lu, Scott H Okuno, et al.
Cell Reports
|
September 21, 2022
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor
Xiyuan Zhang, Hannah E Lou, Vishaka Gopalan, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 203) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 18, 2020
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform Neurofibromas
Lauren H Boal, John Glod, Melissa Spencer, et al.
Acta Neuropathologica Communications
|
June 21, 2024
snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response
Cameron Church, Christian X Fay, Emil Kriukov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor
John Glod, Fernanda I Arnaldez, Lori Wiener, et al.
Pediatric Blood & Cancer
|
June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol
Mary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
Pediatric Blood & Cancer
|
January 6, 2015
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors
Srivandana Akshintala, Leigh Marcus, Katherine E Warren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2012
Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors
Melinda S Merchant, James I Geller, Kristin Baird, et al.
Journal of the National Cancer Institute
|
November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future
Karlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
Neuro-Oncology Advances
|
May 12, 2021
Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo
Sara H Osum, Alexander W Coutts, Dylan J Duerre, et al.
Sarcoma
|
February 25, 2020
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
AeRang Kim, Yao Lu, Scott H Okuno, et al.
Cell Reports
|
September 21, 2022
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor
Xiyuan Zhang, Hannah E Lou, Vishaka Gopalan, et al.
Page
of 21